{"id":29114,"date":"2025-05-21T11:27:33","date_gmt":"2025-05-21T11:27:33","guid":{"rendered":"https:\/\/clarosys.com\/g20\/?post_type=product&#038;p=29114"},"modified":"2025-05-21T11:27:51","modified_gmt":"2025-05-21T11:27:51","slug":"global-diabetes-diagnostics-market-analysis-2022-2028","status":"publish","type":"product","link":"https:\/\/clarosys.com\/g20\/report\/global-diabetes-diagnostics-market-analysis-2022-2028\/","title":{"rendered":"Global Diabetes Diagnostics Market Analysis: 2022-2028"},"content":{"rendered":"<p>The global Diabetes Diagnostics market estimated at US$31.90 billion in the year 2022 is now projected to grow at a CAGR of 7.71% and reach US$49.82 billion by 2028.<\/p>\n<p>The research report\u00a0 provides a comprehensive review of market trends (Technology, Product and Application analysis), market growth drivers, PEST Analysis (Political, Economic, Social and Technological Analysis) Market growth inhibitors, and strategic industry activities and SWOT Analysis of key players in the market. The report provides market estimates and forecast for geographic markets such as the North America (United States, Canada, Mexico and Rest of North America), South America (Brazil, Argentina Chile Colombia Peru Venezuela Ecuador and Rest of South America), Europe (Germany, France, U.K., Russia, Italy, Spain, Sweden, Netherlands, Poland, Austria, Belgium, Finland, Norway, Switzerland, Denmark, Czech Republic, Portugal and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Philippines, Malaysia and Rest of Asia-Pacific), Middle East (Iran, Turkey, Kuwait, UAE, Israel, Oman, Bahrain, Saudi Arabia, Qatar, Egypt and Rest of Middle East) &amp; Africa.<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-3594 size-full\" src=\"https:\/\/clarosys.com\/g20\/wp-content\/uploads\/2015\/08\/Region-Final.jpg\" alt=\"\" width=\"928\" height=\"500\" \/><\/p>\n<p>North American diabetes diagnostics market is expected to grow significantly over the forecast period 2022-2028. Growing prevalence of diabetes and other lifestyle and chronic diseases, ageing population, well-established healthcare infrastructure and wider access to care services, higher healthcare awareness among population, and consumer affluence will drive the diabetes diagnostics market growth. United States contributed around 78% of the total North American diabetes diagnostics market. It is estimated to have a market value of US$11.93 billion in the year 2022. Among the other noteworthy geographic markets are Canada and Mexico, each forecast to grow at 7.69% and 6.44% respectively over the 2022-2028 period.<\/p>\n<p>Asia Pacific diabetes diagnostics market is anticipated to witness an upsurge owing to the increased convenience, shift towards high-calorie energy-rich foods, and increasingly sedentary lifestyles are contributing to an alarming rise in incidence of diabetes in India and China making the countries the global hub for the disease with the highest number of diabetic adults. China is expected to dominate the Asia-Pacific market and reach a market size of US$6.54 billion by 2028.<\/p>\n<p>Within Europe, France, Germany, and the U.K. are the key countries responsible for the significant growth of the regional market. Germany is expected to grow at a fastest CAGR of 8.46% over the forecast period.<\/p>\n<p>Meanwhile, the Middle East &amp; Africa is expected to show limited growth due to the strong presence of under-developed countries in Africa who are still struggling to meet technology standards. However, any growth that the region experiences is expected to come from developing Middle Eastern nations such as Qatar, U.A.E, and Oman due to a similar growth pattern as the Asia Pacific.<\/p>\n<p>Key players profiled in the report include A.Menarini Diagnostics Ltd.; Abbott Diabetes Care, Inc.; Acon Laboratories, Inc.; AgaMatrix, Inc.; Apex Biotechnology Corporation; ARKRAY, Inc.; Ascensia Diabetes Care Holdings AG; B. Braun Melsungen AG; Becton, Dickinson and Company; BIONIME Corporation; Bio-Rad Laboratories, Inc.; Danaher Corporation; Beckman Coulter, Inc.; HemoCue\u00ae AB; DexCom, Inc.; Diazyme Laboratories Inc.; EKF Diagnostics Holdings Plc; LifeScan, Inc.; Medtronic Plc; Nova Biomedical Corporation; OSANG Healthcare Co., Ltd.; Roche Diabetes Care, Inc.; Sanofi S.A.; Sanwa Kagaku Kenkyusho Co, Ltd.; Siemens Healthineers; Sinocare, Inc.; PTS Diagnostics; Trividia Health, Inc.; TaiDoc Technology Corporation; Tandem Diabetes Care, Inc.; Terumo Corporation; Tosoh Bioscience, Inc.; Trinity Biotech Plc; Ypsomed AG, among others.<\/p>\n<p><span style=\"font-size: 18pt;\"><b>Research Methodology<\/b><\/span><\/p>\n<p><img decoding=\"async\" class=\"wp-image-3681 size-full aligncenter\" src=\"https:\/\/clarosys.com\/g20\/wp-content\/uploads\/2019\/10\/Research-Methodology.png\" alt=\"\" width=\"837\" height=\"500\" \/>Table of Contents<\/p>\n<ul>\n<li>Executive Summary<\/li>\n<li>Research Methodology\n<ul>\n<li>Primary Research<\/li>\n<li>Secondary Research<\/li>\n<li>Market Analytics<\/li>\n<li>Revenue Forecasting<\/li>\n<\/ul>\n<\/li>\n<li>Market Overview\n<ul>\n<li>Market Definition<\/li>\n<li>Scope of the Study\n<ul>\n<li>Research Objectives<\/li>\n<li>Assumptions &amp; Limitations<\/li>\n<li>Market Structure<\/li>\n<\/ul>\n<\/li>\n<li>Market Dynamics\n<ul>\n<li>Introduction<\/li>\n<li>Microeconomic Factor Analysis<\/li>\n<li>Market Evolution<\/li>\n<li>Technology Roadmap<\/li>\n<li>Demand-Supply Dynamics<\/li>\n<li>Growth Drivers<\/li>\n<li>Restraints<\/li>\n<li>Opportunities<\/li>\n<li>Challenges<\/li>\n<li>Sustainable Strategies<\/li>\n<\/ul>\n<\/li>\n<li>Market Trend Analysis (Product Analysis, Technology Analysis, Application Analysis)<\/li>\n<li>Industry Analysis\n<ul>\n<li>Profitability analysis<\/li>\n<li>Supply Chain &amp; Value Chain Analysis<\/li>\n<li>Porter\u2019s Five Forces Analysis\n<ul>\n<li>Bargaining power of Suppliers<\/li>\n<li>Bargaining Power of Buyers<\/li>\n<li>Threat of substitutes<\/li>\n<li>Threat of new entrants<\/li>\n<li>Degree of Competition<\/li>\n<\/ul>\n<\/li>\n<li>PEST Analysis<\/li>\n<li>Upstream and downstream profitability analysis and opportunities<\/li>\n<li>COVID-19 impact analysis\n<ul>\n<li>Diabetes diagnostics market<\/li>\n<li>Healthcare &amp; wellness industry<\/li>\n<li>Medical devices industry<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Global Diabetes diagnostics Market Scope <\/strong><span style=\"font-size: 10pt;\">(Market size and projections, 2022-2028)<\/span><\/p>\n<ol>\n<li>Market analysis by Product\n<ol>\n<li>Blood glucose monitoring devices<\/li>\n<li>Non-invasive glucose monitoring<\/li>\n<li>Glucose self-testing systems<\/li>\n<li>Diabetes management systems<\/li>\n<li>Others<\/li>\n<\/ol>\n<\/li>\n<li>Market analysis by type of diabetes\n<ol>\n<li>Prediabetes<\/li>\n<li>Polygenic diabetes\n<ol>\n<li>Type 1 diabetes<\/li>\n<li>Type 2 diabetes<\/li>\n<\/ol>\n<\/li>\n<li>Others<\/li>\n<\/ol>\n<\/li>\n<li>Market analysis by end user\n<ol>\n<li>Hospitals<\/li>\n<li>Specialty diabetes clinics<\/li>\n<li>Diagnostic centers<\/li>\n<li>Outpatient facilities<\/li>\n<li>Home health care providers<\/li>\n<li>Others<\/li>\n<\/ol>\n<\/li>\n<li>Market analysis by distribution channel\n<ol>\n<li>Drug stores &amp; pharmacies<\/li>\n<li>Diabetes clinics\/centers<\/li>\n<li>Others<\/li>\n<\/ol>\n<\/li>\n<li>Emerging trends and technologies\n<ol>\n<li>Real-time glucose sensing and monitoring system<\/li>\n<li>Flash glucose monitoring (FGM)<\/li>\n<li>Minimally-invasive CGM devices<\/li>\n<li>Cloud-enabled CGM devices<\/li>\n<li>Wearable and mobile glucose monitoring systems<\/li>\n<li>Intelligent glucose meters<\/li>\n<li>Smart, connected foot mat<\/li>\n<li>Smart insulin pens<\/li>\n<li>Smart insulin pumps<\/li>\n<li>Smart insulin patches<\/li>\n<li>Others<\/li>\n<\/ol>\n<\/li>\n<li>Market analysis by region\n<ul>\n<li>North America\n<ul>\n<li>US<\/li>\n<li>Canada<\/li>\n<li>Mexico<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li>South America\n<ul>\n<li>Brazil<\/li>\n<li>Argentina<\/li>\n<li>Chile<\/li>\n<li>Colombia<\/li>\n<li>Peru<\/li>\n<li>Venezuela<\/li>\n<li>Ecuador<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li>Europe\n<ul>\n<li>Germany<\/li>\n<li>France<\/li>\n<li>UK<\/li>\n<li>Russia<\/li>\n<li>Italy<\/li>\n<li>Spain<\/li>\n<li>Sweden<\/li>\n<li>Netherlands<\/li>\n<li>Poland<\/li>\n<li>Austria<\/li>\n<li>Belgium<\/li>\n<li>Finland<\/li>\n<li>Norway<\/li>\n<li>Switzerland<\/li>\n<li>Denmark<\/li>\n<li>Czech Republic<\/li>\n<li>Portugal<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li>Asia-Pacific\n<ul>\n<li>China<\/li>\n<li>Japan<\/li>\n<li>South Korea<\/li>\n<li>Taiwan<\/li>\n<li>India<\/li>\n<li>Australia<\/li>\n<li>Indonesia<\/li>\n<li>Philippines<\/li>\n<li>Malaysia<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li>Middle East\n<ul>\n<li>Iran<\/li>\n<li>Turkey<\/li>\n<li>Kuwait<\/li>\n<li>UAE<\/li>\n<li>Israel<\/li>\n<li>Oman<\/li>\n<li>Bahrain<\/li>\n<li>Saudi Arabia<\/li>\n<li>Qatar<\/li>\n<li>Egypt<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li>Africa\n<ul>\n<li>Algeria<\/li>\n<li>Libya<\/li>\n<li>South Africa<\/li>\n<li>Sudan<\/li>\n<li>Zimbabwe<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li>Competitive Landscape\n<ul>\n<li>Introduction<\/li>\n<li>Market share analysis by key market players (North America, South America, Europe, APAC, Africa)<\/li>\n<li>Market Strategy<\/li>\n<li>Mergers and Acquisitions<\/li>\n<li>New Product Launches<\/li>\n<li>Asset Transactions<\/li>\n<li>Financial Announcements<\/li>\n<\/ul>\n<\/li>\n<li>Company Profile (key market players)\n<ul>\n<li>Company profile 1\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 2\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 3\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 4\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 5\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 6\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 7\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 8\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 9\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li>Company profile 10\n<ul>\n<li>Company Overview<\/li>\n<li>Strategic Initiatives<\/li>\n<li>Financial Analysis<\/li>\n<li>Product Benchmarking<\/li>\n<li>SWOT Analysis<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: left;\">Other Companies<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>100+<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The global Diabetes Diagnostics market estimated at US$31.90 billion in the year 2022 is now projected to grow at a CAGR of 7.71% and reach US$49.82 billion by 2028. The research report\u00a0 provides a comprehensive review of market trends (Technology, Product and Application analysis), market growth drivers, PEST Analysis (Political, Economic, Social and Technological Analysis) [&hellip;]<\/p>\n","protected":false},"featured_media":29136,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[200,179],"product_tag":[],"class_list":["post-29114","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-wellness-market-research-reports","product_cat-global-reports","first","instock","sold-individually","shipping-taxable","purchasable","product-type-variable","has-default-attributes","add-to-wishlist-after_add_to_cart"],"_links":{"self":[{"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/product\/29114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/comments?post=29114"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/media\/29136"}],"wp:attachment":[{"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/media?parent=29114"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/product_brand?post=29114"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/product_cat?post=29114"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/clarosys.com\/g20\/wp-json\/wp\/v2\/product_tag?post=29114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}